FI922826A0 - Piperidinfoereningar och farmaceutisk komposition. - Google Patents

Piperidinfoereningar och farmaceutisk komposition.

Info

Publication number
FI922826A0
FI922826A0 FI922826A FI922826A FI922826A0 FI 922826 A0 FI922826 A0 FI 922826A0 FI 922826 A FI922826 A FI 922826A FI 922826 A FI922826 A FI 922826A FI 922826 A0 FI922826 A0 FI 922826A0
Authority
FI
Finland
Prior art keywords
alkyl
hydrogen
piperidinfoereningar
pharmaceutisk
komposition
Prior art date
Application number
FI922826A
Other languages
English (en)
Finnish (fi)
Other versions
FI922826A (fi
Inventor
Palle Jakobsen
Ursula Sonnewald
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI922826A publication Critical patent/FI922826A/fi
Publication of FI922826A0 publication Critical patent/FI922826A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI922826A 1989-12-18 1992-06-17 Piperidinfoereningar och farmaceutisk komposition. FI922826A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK640289A DK640289D0 (da) 1989-12-18 1989-12-18 Ny heterocyklisk kemi
PCT/DK1990/000325 WO1991009032A1 (en) 1989-12-18 1990-12-11 Piperidine compounds and a pharmaceutical composition

Publications (2)

Publication Number Publication Date
FI922826A FI922826A (fi) 1992-06-17
FI922826A0 true FI922826A0 (fi) 1992-06-17

Family

ID=8148694

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922826A FI922826A0 (fi) 1989-12-18 1992-06-17 Piperidinfoereningar och farmaceutisk komposition.

Country Status (18)

Country Link
US (1) US5102894A (ja)
EP (1) EP0505465B1 (ja)
JP (1) JPH05502867A (ja)
CN (1) CN1052674A (ja)
AT (1) ATE135704T1 (ja)
AU (1) AU645722B2 (ja)
CA (1) CA2071480A1 (ja)
DE (1) DE69026110T2 (ja)
DK (2) DK640289D0 (ja)
ES (1) ES2084151T3 (ja)
FI (1) FI922826A0 (ja)
IE (1) IE904435A1 (ja)
IL (2) IL96592A0 (ja)
NO (2) NO922313D0 (ja)
PT (1) PT96235B (ja)
WO (1) WO1991009032A1 (ja)
ZA (1) ZA9010183B (ja)
ZW (1) ZW19190A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763589B1 (fr) * 1997-05-22 2001-01-05 Centre Nat Rech Scient Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
CA2422055A1 (en) 2000-09-11 2002-03-21 Sepracor, Inc. Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
US7531555B2 (en) 2003-10-01 2009-05-12 University Of Florida Research Foundation, Inc. Compositions and methods for selective inhibition of nicotine acetylcholine receptors
JP5199678B2 (ja) 2005-02-23 2013-05-15 プレクサ ファーマシューティカルズ， インコーポレイテッド 運動障害および他のｃｎｓ適応症の処置に使用することにおけるドーパミントランスポータ阻害剤
US20090054489A1 (en) * 2005-02-23 2009-02-26 Prexa Pharmaceuticals, Inc. Multimediator Dopamine Transport Inhibitors, and Uses Related Thereto

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895965A (en) * 1959-07-21 Process for the production of
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
DK588289D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Ny heterocyklisk kemi

Also Published As

Publication number Publication date
EP0505465B1 (en) 1996-03-20
WO1991009032A1 (en) 1991-06-27
ES2084151T3 (es) 1996-05-01
DK0505465T3 (da) 1996-08-05
NO922313L (no) 1992-06-12
PT96235B (pt) 1998-06-30
PT96235A (pt) 1991-09-30
JPH05502867A (ja) 1993-05-20
CA2071480A1 (en) 1991-06-19
AU645722B2 (en) 1994-01-20
FI922826A (fi) 1992-06-17
DE69026110D1 (de) 1996-04-25
DK640289D0 (da) 1989-12-18
IE904435A1 (en) 1991-06-19
NO1994003I1 (no) 1994-07-01
DE69026110T2 (de) 1996-10-02
IL96592A (en) 1995-06-29
IL96592A0 (en) 1991-09-16
AU6971691A (en) 1991-07-18
ATE135704T1 (de) 1996-04-15
NO922313D0 (no) 1992-06-12
ZW19190A1 (en) 1991-06-05
EP0505465A1 (en) 1992-09-30
ZA9010183B (en) 1991-10-30
US5102894A (en) 1992-04-07
CN1052674A (zh) 1991-07-03

Similar Documents

Publication Publication Date Title
DK0699191T3 (da) Sulfonamider og derivater deraf, der modulerer aktiviteten af endotelin
FI911330A (fi) 1,4,7,10-tetra-azacyklododekan -butyltrioler, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
FI922826A0 (fi) Piperidinfoereningar och farmaceutisk komposition.
FI892675A0 (fi) 2,6-dihalogenpyridin-3 -karboxylsyraderivat och deras framstaellning.
FI885592A0 (fi) Aryloxifenylpropylaminer, deras framstaellning och anvaendning.
FI872555A (fi) Antiallergiska och antiinflammatoriska aemnen.
NO930830L (no) Nye beta-aminosyrederivater
DE68926418D1 (de) S'-adenosyl-methionin-decarboxylase-Inhibitoren
FI840743A0 (fi) N-(3-trifluormetylfenyl)-n'-propargylpiperazin, dess framstaellning och anvaendning
ES554830A0 (es) Procedimiento para preparar derivados de 1,3-oxatiano
EA200100073A1 (ru) Изохинолины в качестве ингибиторов урокиназы
PT784973E (pt) Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
NO961891D0 (no) 15-deoksyspergualin analogier, deres prepareringsmetode og deres bruk i terapier
DK17785D0 (da) Propanolderivater
DK588289D0 (da) Ny heterocyklisk kemi
TH36857A (th) อนุพันธ์เบนซามิดีน
DE3262971D1 (en) Phenylethylthiazole derivatives, their preparation and their therapeutical use
SU1774617A1 (ru) Производные 3-хлор-1,4-нафтохинона, обладающие бактерицидными и фунгицидными свойствами

Legal Events

Date Code Title Description
FD Application lapsed